Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
2.670
-0.100 (-3.61%)
At close: May 30, 2025, 4:00 PM
2.720
+0.050 (1.87%)
After-hours: May 30, 2025, 4:47 PM EDT
Humacyte Market Cap
Humacyte has a market cap or net worth of $412.62 million as of May 30, 2025. Its market cap has decreased by -36.77% in one year.
Market Cap
412.62M
Enterprise Value
432.28M
1-Year Change
-36.77%
Ranking
Category
Stock Price
$2.67
Market Cap Chart
Since December 1, 2020, Humacyte's market cap has increased from $124.31M to $412.62M, an increase of 231.93%. That is a compound annual growth rate of 30.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2025 | 429.68M | -33.87% |
| Dec 31, 2024 | 649.78M | 120.90% |
| Dec 29, 2023 | 294.15M | 35.19% |
| Dec 30, 2022 | 217.58M | -70.86% |
| Dec 31, 2021 | 746.77M | 471.21% |
| Dec 31, 2020 | 130.74M | 5.17% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 648.68B |
| Johnson & Johnson | 369.52B |
| AbbVie | 327.88B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 270.48B |
| Abbott Laboratories | 231.14B |
| Novartis AG | 219.70B |
| AstraZeneca | 217.50B |